Studies have found that overexpression of apoptosis-related factors, such as nuclear transcription factor (NF-κB) and B-cell lymphoma 2 (Bcl-2), can inhibit cell apoptosis, thereby reducing the sensitivity of breast cancer cells to drugs and causing drug resistance [56]. Here, NFKB1 is linked to breast carcinoma.